Targeting TPX2-dependent lineage plasticity by CDK4/6 inhibition reverses therapy resistance in neuroendocrine bladder carcinoma. (linkinghub.elsevier.com)

Authors: Chen Z … Chen X Journal: Cell Reports Medicine Published: 2026-04-21 DOI: https://doi.org/10.1016/j.xcrm.2026.102712